Medindia

X

GSK Biologicals Interested in Buying BE's Vaccine Unit

by Dr. Trupti Shirole on  April 22, 2011 at 8:21 PM Indian Health News   - G J E 4
A division of global drug giant Glaxo, GlaxoSmithKline Biologicals based in Belgium is in talks with the Hyderabad-based Biological E Ltd (BE) to purchase its vaccines division.
 GSK Biologicals Interested in Buying BE's Vaccine Unit
GSK Biologicals Interested in Buying BE's Vaccine Unit
Advertisement

This vaccine division produces and markets a range of pediatric and adult vaccines. The Diphtheria and Tetanus vaccine has given the company a sizeable market share in the Indian vaccine market. BE claims to be the first private sector company to enter the vaccines market.

Advertisement
Recently Glaxo's current plant in Nasik faced some constraints in supplying vaccines and therefore it would be interested in buying companies with modern manufacturing facilities approved by international agencies like US FDA. The BE vaccine unit buyout will give GSK Biologicals additional capacity in India.


Source: Medindia
Advertisement

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
Notify me when reply is posted I agree to the terms and conditions

You May Also Like

Advertisement
View All